Peter Feinberg - 03 Aug 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
By: /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
03 Aug 2021
Net transactions value
+$4,375,005
Form type
4
Filing time
04 Aug 2021, 06:06:41 UTC
Previous filing
13 Sep 2021
Next filing
15 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Conversion of derivative security +133,572 +108% 257,325 03 Aug 2021 See Foonote F1, F2
transaction IMRX Class A Common Stock Purchase $1,937,505 +129,167 +50% $15.00 386,492 03 Aug 2021 See Foonote F2
transaction IMRX Class A Common Stock Conversion of derivative security +123,155 +55% 347,401 03 Aug 2021 See Foonote F1, F3
transaction IMRX Class A Common Stock Purchase $1,937,505 +129,167 +37% $15.00 476,568 03 Aug 2021 See Foonote F3
transaction IMRX Class A Common Stock Conversion of derivative security +82,108 82,108 03 Aug 2021 See Foonote F1, F4
transaction IMRX Class A Common Stock Purchase $499,995 +33,333 +41% $15.00 115,441 03 Aug 2021 See Foonote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Series A Preferred Stock Conversion of derivative security -102,926 -100% 0 03 Aug 2021 Class A Common Stock 102,926 See footnote F1, F2
transaction IMRX Series A Preferred Stock Conversion of derivative security -92,509 -100% 0 03 Aug 2021 Class A Common Stock 92,509 See footnote F1, F3
transaction IMRX Series A Preferred Stock Conversion of derivative security -51,462 -100% 0 03 Aug 2021 Class A Common Stock 51,462 See footnote F1, F4
transaction IMRX Series B Preferred Stock Conversion of derivative security -30,646 -100% 0 03 Aug 2021 Class A Common Stock 30,646 See footnote F1, F2
transaction IMRX Series B Preferred Stock Conversion of derivative security -30,646 -100% 0 03 Aug 2021 Class A Common Stock 30,646 See footnote F1, F3
transaction IMRX Series B Preferred Stock Conversion of derivative security -30,646 -100% 0 03 Aug 2021 Class A Common Stock 30,646 See footnote F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
F2 Mr. Feinberg is a General Partner of PF Associates L.P.
F3 Mr. Feinberg is a General Partner of PEF LLC.
F4 Mr. Feinberg is a General Partner of S4K Investments LLC.